Literature DB >> 25526313

The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells.

Peter T Sage1, Alison M Paterson1, Scott B Lovitch2, Arlene H Sharpe3.   

Abstract

The receptor CTLA-4 has been implicated in controlling B cell responses, but the mechanisms by which CTLA-4 regulates antibody production are not known. Here we showed deletion of CTLA-4 in adult mice increased Tfh and Tfr cell numbers and augmented B cell responses. In the effector phase, loss of CTLA-4 on Tfh cells resulted in heightened B cell responses, whereas loss of CTLA-4 on Tfr cells resulted in defective suppression of antigen-specific antibody responses. We also found that non-Tfr Treg cells could suppress B cell responses through CTLA-4 and that Treg and/or Tfr cells might downregulate B7-2 on B cells outside germinal centers as a means of suppression. Within the germinal center, however, Tfr cells potently suppress B cells through CTLA-4, but with a mechanism independent of altering B7-1 or B7-2. Thus, we identify multifaceted regulatory roles for CTLA-4 in Tfh, Tfr, and Treg cells, which together control humoral immunity.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25526313      PMCID: PMC4309019          DOI: 10.1016/j.immuni.2014.12.005

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  39 in total

1.  CTLA-4 regulates induction of anergy in vivo.

Authors:  R J Greenwald; V A Boussiotis; R B Lorsbach; A K Abbas; A H Sharpe
Journal:  Immunity       Date:  2001-02       Impact factor: 31.745

2.  CTLA-4 differentially regulates T cell responses to endogenous tissue protein versus exogenous immunogen.

Authors:  Lucy S K Walker; Lara J Ausubel; Anna Chodos; Nyree Bekarian; Abul K Abbas
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

3.  Established T cell-driven germinal center B cell proliferation is independent of CD28 signaling but is tightly regulated through CTLA-4.

Authors:  Lucy S K Walker; Helen E Wiggett; Fabrina M C Gaspal; Chandra R Raykundalia; Margaret D Goodall; Kai-Michael Toellner; Peter J L Lane
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

4.  Circulating T follicular regulatory and helper cells have memory-like properties.

Authors:  Peter T Sage; David Alvarez; Jernej Godec; Ulrich H von Andrian; Arlene H Sharpe
Journal:  J Clin Invest       Date:  2014-10-27       Impact factor: 14.808

5.  PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells.

Authors:  Kim L Good-Jacobson; Courtney G Szumilas; Lieping Chen; Arlene H Sharpe; Mary M Tomayko; Mark J Shlomchik
Journal:  Nat Immunol       Date:  2010-05-09       Impact factor: 25.606

6.  Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.

Authors:  E A Tivol; F Borriello; A N Schweitzer; W P Lynch; J A Bluestone; A H Sharpe
Journal:  Immunity       Date:  1995-11       Impact factor: 31.745

7.  CTLA-4 regulates the requirement for cytokine-induced signals in T(H)2 lineage commitment.

Authors:  Hélène Bour-Jordan; Jane L Grogan; Qizhi Tang; Julie A Auger; Richard M Locksley; Jeffrey A Bluestone
Journal:  Nat Immunol       Date:  2003-01-13       Impact factor: 25.606

8.  Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.

Authors:  P Waterhouse; J M Penninger; E Timms; A Wakeham; A Shahinian; K P Lee; C B Thompson; H Griesser; T W Mak
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

9.  CTLA-4 ligation blocks CD28-dependent T cell activation.

Authors:  T L Walunas; C Y Bakker; J A Bluestone
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

10.  Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production.

Authors:  D Breitfeld; L Ohl; E Kremmer; J Ellwart; F Sallusto; M Lipp; R Förster
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

View more
  176 in total

1.  Systemic lupus erythematosus in 2015: Cellular and metabolic requirements of effector T cells.

Authors:  George C Tsokos
Journal:  Nat Rev Rheumatol       Date:  2016-01-05       Impact factor: 20.543

Review 2.  The regulation of T follicular helper responses during infection.

Authors:  Noah S Butler; Divine I Kulu
Journal:  Curr Opin Immunol       Date:  2015-03-02       Impact factor: 7.486

3.  Selective CD28 Blockade Results in Superior Inhibition of Donor-Specific T Follicular Helper Cell and Antibody Responses Relative to CTLA4-Ig.

Authors:  I R Badell; G M La Muraglia; D Liu; M E Wagener; G Ding; M L Ford
Journal:  Am J Transplant       Date:  2017-08-14       Impact factor: 8.086

4.  Foxp1 Negatively Regulates T Follicular Helper Cell Differentiation and Germinal Center Responses by Controlling Cell Migration and CTLA-4.

Authors:  Bi Shi; Jianlin Geng; Yin-Hu Wang; Hairong Wei; Beth Walters; Wei Li; Xuerui Luo; Anna Stevens; Melanie Pittman; Bin Li; Sunnie R Thompson; Hui Hu
Journal:  J Immunol       Date:  2017-12-06       Impact factor: 5.422

Review 5.  T Follicular Regulatory Cells and Antibody Responses in Transplantation.

Authors:  Elizabeth F Wallin
Journal:  Transplantation       Date:  2018-10       Impact factor: 4.939

6.  Suppression by TFR cells leads to durable and selective inhibition of B cell effector function.

Authors:  Peter T Sage; Noga Ron-Harel; Vikram R Juneja; Debattama R Sen; Seth Maleri; Waradon Sungnak; Vijay K Kuchroo; W Nicholas Haining; Nicolas Chevrier; Marcia Haigis; Arlene H Sharpe
Journal:  Nat Immunol       Date:  2016-10-03       Impact factor: 25.606

Review 7.  Restoring Regulatory T Cells in Type 1 Diabetes.

Authors:  Allyson Spence; Qizhi Tang
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

Review 8.  Regulatory T Cells: Central Concepts from Ontogeny to Therapy.

Authors:  Bernard Khor
Journal:  Transfus Med Rev       Date:  2016-07-26

Review 9.  Moving towards personalized treatments of immune-related adverse events.

Authors:  Khashayar Esfahani; Arielle Elkrief; Cassandra Calabrese; Réjean Lapointe; Marie Hudson; Bertrand Routy; Wilson H Miller; Leonard Calabrese
Journal:  Nat Rev Clin Oncol       Date:  2020-04-03       Impact factor: 66.675

10.  Cancers from Novel Pole-Mutant Mouse Models Provide Insights into Polymerase-Mediated Hypermutagenesis and Immune Checkpoint Blockade.

Authors:  Melissa A Galati; Karl P Hodel; Zachary F Pursell; Uri Tabori; Miki S Gams; Sumedha Sudhaman; Taylor Bridge; Walter J Zahurancik; Nathan A Ungerleider; Vivian S Park; Ayse B Ercan; Lazar Joksimovic; Iram Siddiqui; Robert Siddaway; Melissa Edwards; Richard de Borja; Dana Elshaer; Jiil Chung; Victoria J Forster; Nuno M Nunes; Melyssa Aronson; Xia Wang; Jagadeesh Ramdas; Andrea Seeley; Tomasz Sarosiek; Gavin P Dunn; Jonathan N Byrd; Oz Mordechai; Carol Durno; Alberto Martin; Adam Shlien; Eric Bouffet; Zucai Suo; James G Jackson; Cynthia E Hawkins; Cynthia J Guidos
Journal:  Cancer Res       Date:  2020-09-16       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.